# Altor Bioscience Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/altor-bioscience

- Industry: Pharmaceuticals
- Headquarters: Miramar, US
- Website: www.altorbioscience.com
- Total disclosed funding: $18M
- Latest round: Series E (Feb 28, 2013)
- Investors on record: 6

## About

Founded in 2002 and based in Florida, US, Altor Bioscience operates as a biopharmaceutical company that develops immunotherapies for the treatment of cancer and viral infections.

## Funding rounds

- Series E, Feb 28, 2013, $5.5M — Sanderling Ventures
- Series D, Jul 20, 2012, $5.1M — Sanderling Ventures
- Series D, Jan 18, 2011, $6.2M — Sanderling Ventures, TVM Capital Life Science, Radius Ventures, New World Angels, Bill & Melinda Gates Foundation, Small Business Innovation Research
- Series C, Oct 26, 2009, $1.2M — Sanderling Ventures

## Investors

- Sanderling Ventures (https://capitalatlas.ai/funds/sanderling-ventures) — Series C, Series D, Series E
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series D
- Radius Ventures (https://capitalatlas.ai/funds/radius-ventures) — Series D
- New World Angels (https://capitalatlas.ai/funds/new-world-angels) — Series D
- Bill & Melinda Gates Foundation — Series D
- Small Business Innovation Research — Series D